Sarepta Therapeutics (SRPT) Other Operating Expenses (2016 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Other Operating Expenses of $109.5 million for Q1 2026, down 20.78% year-over-year from $138.2 million in Q1 2025, and down 72.59% quarter-over-quarter from $399.4 million in Q4 2025.
Sarepta Therapeutics (SRPT) Other Operating Expenses (2016 - 2026) Analysis & Trends
Sarepta Therapeutics' Other Operating Expenses history runs 11 years deep, the most recent figure standing at $109.5 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 20.78% year-over-year to $109.5 million; the TTM figure through Mar 2026 stood at $813.5 million (up 488.81% YoY), while the FY2023 annual figure was $102.0 million, changed N/A from the prior year.
- Other Operating Expenses for Q1 2026 stood at $109.5 million, down from $399.4 million in the prior quarter.
- The five-year high for Other Operating Expenses was $399.4 million in Q4 2025, with the low at $31.6 million in Q1 2022.
- The 5-year median for Other Operating Expenses is $109.5 million (2026), against an average of $130.2 million.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses soared 170.06% in 2025, then declined 20.78% in 2026.
- Sarepta Therapeutics' Other Operating Expenses stood at $31.6 million in 2022, then soared by 222.57% to $102.0 million in 2023, then sank by 49.84% to $51.2 million in 2024, then soared by 680.66% to $399.4 million in 2025, then slumped by 72.59% to $109.5 million in 2026.
- Business Quant data shows SRPT's Other Operating Expenses at $109.5 million in Q1 2026, $399.4 million in Q4 2025, and $151.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150.10 Mn |
| Mar 31, 2026 | 109.46 Mn |
| Dec 31, 2025 | 399.39 Mn |
| Sep 30, 2025 | 151.46 Mn |
| Jun 30, 2025 | 153.23 Mn |
| Mar 31, 2025 | 138.17 Mn |
| Mar 31, 2024 | 51.16 Mn |
| Jun 30, 2023 | 102.00 Mn |
| Mar 31, 2023 | 35.20 Mn |
| Mar 31, 2022 | 31.62 Mn |
| Jun 30, 2021 | 102.00 Mn |
| Mar 31, 2021 | 32.52 Mn |
| Dec 31, 2020 | -17.77 Mn |
| Sep 30, 2020 | -14.34 Mn |
| Jun 30, 2020 | -12.45 Mn |
| Mar 31, 2020 | 108.07 Mn |
| Dec 31, 2019 | -4.77 Mn |
| Sep 30, 2019 | -2.51 Mn |
| Jun 30, 2019 | -862,000.00 |
| Mar 31, 2019 | -172,000.00 |